Greenlight Biosciences Holdings Pbc  (GRNA)
Other Ticker:  
Price: $0.2995 $0.00 -0.033%
Day's High: $0.304 Week Perf: 0.47 %
Day's Low: $ 0.30 30 Day Perf: 2.92 %
Volume (M): 143 52 Wk High: $ 0.58
Volume (M$): $ 43 52 Wk Avg: $0.33
Open: $0.30 52 Wk Low: $0.18

 Market Capitalization (Millions $) 45
 Shares Outstanding (Millions) 152
 Employees -
 Revenues (TTM) (Millions $) 10
 Net Income (TTM) (Millions $) -157
 Cash Flow (TTM) (Millions $) -51
 Capital Exp. (TTM) (Millions $) 28

Greenlight Biosciences Holdings Pbc
Greenlight Biosciences Holdings Pbc is a biotechnology company that specializes in developing sustainable and environmentally friendly solutions for agriculture, energy, and healthcare sectors. The company focuses on harnessing the power of biology to address global challenges such as food production, carbon emissions, and disease control.

Greenlight Biosciences utilizes a proprietary platform called Cell-Free Biology that enables them to efficiently produce high-quality RNA, which can be used to create a wide range of products. This technology allows the company to rapidly develop and scale their solutions, making their products cost-effective and accessible.

The company's focus areas include crop protection, where they develop RNA-based solutions to protect crops from pests and diseases, leading to increased yields and reduced use of chemical pesticides. In the energy sector, Greenlight Biosciences is working on sustainable and renewable solutions, including biofuels and sustainable products for industrial applications. In the healthcare field, the company is focused on developing RNA-based therapies and vaccines for diseases such as COVID-19 and cancer.

Greenlight Biosciences has partnerships with various organizations, including industry leaders and academic institutions, to advance their research and development efforts. They are committed to providing sustainable solutions that have a positive impact on the environment and human health.

   Company Address: 29 Hartwell Avenue Lexington 2421 MA
   Company Phone Number: 616-8188   Stock Exchange / Ticker: NASDAQ GRNA
   GRNA is expected to report next financial results on March 27, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Greenlight Biosciences Holdings Pbc

Greenlight Biosciences Holdings Pbc Reports Massive Revenue Growth in Q1 2023 Despite Losses

Greenlight Biosciences Holdings Pbc is a leading biotechnology company that has been in operation for several years now. The company is primarily focused on various areas of biotechnology, including developing RNA-based solutions for various applications, including the production of sustainable food and pharmaceuticals.
Despite the notable progress made in the first quarter of 2023, with the company recording a revenue growth of 1386.381% to $3.82 million, the company still reported a cumulative net loss of $-157 million. This resulted in a negative return on investment (ROI) of -174.88%, a situation that is not unusual for companies in the early stages of growth.


Greenlight Biosciences Holdings Pbc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com